Showing 1 - 2 results of 2 for search 'Matthew H Taylor', query time: 0.02s Refine Results
  1. 1
    Phase I dose escalation study of IO-108, an anti-LILRB2 antibody, in patients with advanced solid tumors

    Phase I dose escalation study of IO-108, an anti-LILRB2 antibody, in patients with advanced solid tumors by Ying Zhu, Tao Huang, John Powderly, Aung Naing, Manish R Patel, Matthew H Taylor, Rong Deng, Kyu Hong, Luke Chung, Hongyu Tian, Wen Hong Lin, Paul Woodard, Nathan Siemers, Hong Xiang, Donna Valencia, X Charlene Liao, Xiao Min Schebye

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis

    Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis by James L Gulley, Manish R Patel, Keun-Wook Lee, Luc Dirix, Mary Ruisi, Jeffrey R Infante, Patrick Schöffski, Alain Ravaud, Ding Wang, Andrea B Apolo, John A Ellerton, Manish Agrawal, Michael S Gordon, Raid Aljumaily, Theodore Gourdin, Matthew H Taylor, Juliane Manitz, Gregory Pennock

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: